"Neonatal hemochromatosis": A re-vision

Hepatology

Volumn 51, Issue 6, 2010, Pages 1888-1889

  Knisely, A S ^a   Vergani, Diego ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIBODY; PROTEIN;

AUTOIMMUNE DISEASE; CELL MEMBRANE; COMPLEMENT ACTIVATION; EDITORIAL; HEMOCHROMATOSIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER FAILURE; NEONATAL HEMOCHROMATOSIS; NEWBORN DISEASE; PRIORITY JOURNAL;

EID: 77952691285     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23728     Document Type: Editorial

References (15)

1. Cottier H. Über ein der Hämochromatose vergleichbares Krankheitsbild bei Neugeborenen. Schweiz Med Wochenschr 1957;37:39-43.
2. Cottier H. Transfusionssiderose und allgemeine Hämochromatose. Schweiz Med Wochenschr 1952;82:873-877.
3. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am 2003;32:877-889.
4. Verloes A, Temple IK, Hubert AF, Hope P, Gould S, Debauche C, et al. Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet 1996;33:444-449.
5. Kelly AL, Lunt PW, Rodrigues F, Berry PJ, Flynn DM, McKiernan PJ, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 2001;38:599-610.
6. Schoenlebe J, Buyon JP, Zitelli BJ, Friedman D, Greco MA, Knisely AS. Neonatal hemochromatosis associated with maternal autoantibodies against Ro/SS-A and La/SS-B ribonucleoproteins. Am J Dis Child 1993;147:1072-1075.
7. Whitington PF. Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis 2007;27:243-250.
8. Pan X, Kelly S, Melin-Aldana H, Malladi P, Whitington PF. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. HEPATOLOGY 2010;51:2061-2068.
9. Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodriguez de Cordoba S, Kirschfink M. Complement analysis in the 21st century. Mol Immunol 2007;44:3838-3849.
10. Porcel JM, Peakman M, Senaldi G, Vergani D. Methods for assessing complement activation in the clinical immunology laboratory. J Immunol Methods 1993;157:1-9.
11. Lee LA. The clinical spectrum of neonatal lupus. Arch Dermatol Res 2009;301:107-110.
12. Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008;121:1615-1621.
13. Knisely AS. Iron and pediatric liver disease. Semin Liver Dis 1994;14:229-235.
14. Pasteur L. Discours (prononcé à Douai, le 7 Décembre 1854, à l'occasion de l'installation solennelle de la Faculté des Lettres de Douai et de la Faculté des Sciences de Lille). In: Pasteur Vallery-Radot L, ed. OEuvres de Pasteur. Vol VII. Paris, France: Masson; 1939:131.
15. Pasteur L. Discours prononcé à l'inauguration de l'Institut Pasteur, le 14 Novembre 1888. In: Pasteur Vallery-Radot L, ed. OEuvres de Pasteur. Vol VII. Paris, France: Masson; 1939:419.